Alberto Bazzocchi
Alberto Bazzocchi, MD, PhD
Dr. Alberto Bazzocchi is a radiology consultant at the Rizzoli Orthopaedic Institute in Bologna, Italy. He is an adjunct Professor of Radiology at the University of Bologna and is being qualified as full professor of Radiology by the Italian Ministry of Education, University and Research. Dr Bazzocchi has participated in numerous research programs. He designed and coordinated research projects and was the winner of national and international calls. He has authored over 100 articles and 10 book chapters and contributed to over 250 works presented at congresses worldwide.
David Brenin  
David R. Brenin, MD
Dr. David Brenin is the M.C. Wilhelm Professor in Diseases of the Breast and the Chief of Breast and Melanoma Surgery at the University of Virginia Medical Center. He is the principal investigator of an international study evaluating ultrasound-guided focused ultrasound ablation (FUSA) of breast fibroadenoma and a co-investigator of a study evaluating the combination of FUSA and immunotherapy for the treatment of breast cancer.
Jin Woo Chang  
Jin Woo Chang, MD, PhD
Dr. Jin Woo Chang is a Professor in the Department of Neurosurgery and the Director of the Brain Research Institute at Yonsei University College of Medicine, Seoul, Korea. His clinical work has included using focused ultrasound to treat movement disorders and pioneering research into treating psychiatric disorders like OCD and depression. He served as the honorary president of the 5th International Symposium on Focused Ultrasound in 2016.
Hong Chen  
Hong Chen, PhD
Dr. Hong Chen joined the Washington University in St. Louis faculty in 2015 as an assistant professor of biomedical engineering in the School of Engineering & Applied Science and of radiation oncology at the School of Medicine from Columbia University, where she was a postdoctoral research scientist in the Department of Biomedical Engineering. She received her PhD from the University of Washington.
Reese Cosgrove
Rees Cosgrove, MD, FRCSC
Dr. Rees Cosgrove is the Director of Epilepsy and Functional Neurosurgery at Brigham and Women’s Hospital in Boston. He is also Director of the Neurosurgery Residency Training Program. As a leader in academic neurosurgery, he is a member of the executive committee of the World Society of Stereotactic and Functional Neurosurgery; past president of the American Society of Stereotactic and Functional Neurosurgery and an active member of the American Association of Neurosurgeons; the Congress of Neurological Surgeons; the American Academy of Neurological Surgery; and the Society of Neurological Surgeons.
Gregory Daniel
Gregory B. Daniel, DVM
Dr. Gregory Daniel is a veterinary radiologist and professor of radiology in the Department of Small Animal Clinical Sciences at the the Virginia-Maryland College of Veterinary Medicine. He has served as interim dean there since November 2017, and will return to the faculty as a radiologist in June 2020. He was also professor and director of radiological services at the University of Tennessee's College of Veterinary Medicine in Knoxville. His teaching and research focus on nuclear medicine and diagnostic imaging.
Gil Dubernard
Gil Dubernard, MD, PhD
Professor Gil Dubernard is a Gynecologic surgeon with an ultrasound expertise. As a result of this combination he has developed a new technique for diagnosing endometriosis, which is known as 3D Rectosonography.In 2007, Prof. Dubernard joined the team of Professor RUDIGOZ at Croix-Rousse Hospital (Lyon, France). In 2010, he was named University Professor-Hospital Practitioner, and became manager of the Obstetrics Gynecology department in 2015. The next year, he joined LabTAU while supervising the PhD Thesis of Doctor Charles-André PHILIP. The LabTAU team have carried-out their first global phase I study on the treatment of rectal endometriosis with focused ultrasound in collaboration with the device manufacturer EDAP TMS.
Eitan
Renana Eitan, MD
Dr. Renana Eitan is a researcher at The Brigham and Women’s Hospital, Harvard Medical School (since 2016) and head of neuropsychiatry unit at the Jerusalem Mental Health Center, Hebrew University (since 2019). She studied medicine at The Hebrew University Medical School (2001) and psychiatry at The Hadassah-Hebrew University Medical Center (2009). She was the founding director of the first neuropsychiatric unit in Israel (2011-2015). Dr. Eitan is one the pioneers of deep brain stimulation research in psychiatry. She and her colleagues focus on the development of new functional electrophysiological techniques in human patients and non-human primates to localize and characterize brain circuitry dysfunction underlying psychiatric disorders. They have recently initiated a novel deep brain stimulation study to treat negative symptoms of schizophrenia.
Mark Emberton
Mark Emberton, MD
Prof. Mark Emberton applies his expertise in three influential roles: leading the Faculty of Medical Sciences at University College London (UCL) as its Dean, treating patients at University College London Hospital (UCLH), and researching prostate cancer. His work to evaluate the effectiveness of self-management for chronic male lower urinary tract symptoms, led to the development of a self-management intervention programme that saves the NHS around £20 million annually. Prof. Emberton also oversaw the UCL trial of multiparametric MRI (mpMRI) as a first line investigation for men suspected of having clinically localised prostate cancer.
Kathy Ferrara
Katherine W. Ferrara, PhD
Dr. Katherine Ferrara is a Professor of Radiology at Stanford University. Her laboratory is known for early work in aspects of ultrasonics and has more recently expanded their focus to broadly investigate molecular imaging and drug delivery. Dr. Ferrara received her PhD in 1989 from the University of California, Davis. Prior to her PhD, Dr. Ferrara was a project engineer for General Electric Medical Systems, involved in the development of early magnetic resonance imaging and ultrasound systems. Following an appointment as an Associate Professor in the Department of Biomedical Engineering at the University of Virginia, Charlottesville, Dr. Ferrara served as the founding chair of the Department of Biomedical Engineering at UC Davis. 
Paul Fishman
Paul Fishman, MD, PhD
Dr. Paul Fishman is Professor of Neurology, Pharmacology and Neurobiology at the University of Maryland School of Medicine, and Chief of Neurology for the VA Maryland Health Care System. With dual training in Neuroscience and Neurology, his research interest is the translation of novel therapies for neurodegenerative diseases. He co-founded programs for neurotoxin therapeutics and deep brain stimulation. He is also a founding member of focused ultrasound Center of Excellence at the University of Maryland.
Jessica Foley
Jessica Foley, PhD
Dr. Jessica Foley is Chief Scientific Officer at the Focused Ultrasound Foundation, where she guides the strategy, development, and implementation of the scientific and research programs and activities within the Foundation and aligns these with communications and development efforts. She also leads alliance-building efforts with external stakeholders including (but not limited to) governmental policymakers, regulatory agencies, and disease-specific foundations whose interests are complementary to those of the Foundation. She is a representative and advocate for the Foundation and the focused ultrasound community among a wide variety of stakeholders. Dr. Foley joined the Foundation in 2012 after a more than 11-year career in the field of focused ultrasound that spanned academic, industrial and government worlds. 
Jessica Foley
Nathan B. Fountain, MD
Dr. Nathan B. Fountain is the Thomas E. Worrell Jr. Professor of Neurology and Epileptology and Director of the F.E. Dreifuss Comprehensive Epilepsy Program at the University of Virginia, where he completed neurology residency as well as clinical and research epilepsy fellowships. Dr. Fountain’s research includes investigator initiated and NIH and industry sponsored studies of drugs and devices for epilepsy, including almost all of the current treatments for epilepsy. Other research interests from more than 100 publications include studies of the natural history of changes in seizure frequency, status epilepticus, and improving quality of epilepsy care. He is Past-President of the National Association of Epilepsy Centers, Co-chair of the Epilepsy Foundation’s Research Roundtable for Epilepsy, and chair of the FDA Advisory Committee for Peripheral and Central Nervous System Drugs.
Dheeraj Gandhi
Dheeraj Gandhi, MBBS
Dr. Dheeraj Gandhi is Professor of Radiology, Neurology and Neurosurgery at University of Maryland School of Medicine. He directs the Interventional Neuroradiology Program and co-directs the Center of Metabolic Imaging and Therapeutics. His clinical and research interests focus on minimally invasive treatments for intracranial aneurysms and stroke as well as developing image-based direct targeting methods for focused ultrasound procedures.
Michael Gofeld
Michael Gofeld, MD, PhD
Dr. Michael Gofeld is Acting Medical Director at Silver Medical Group, Centre for Pain Care. He also opened a specialized practice, Unika Medical Centre, to focus on the multifaceted assessment of post-traumatic chronic pain, headaches and concussions. Previously, Dr. Gofeld substantially contributed to the development and launching of the Toronto Academic Pain Medicine Institute (TAPMI). He served as an interim Medical Director of the Women’s College Pain Clinic, as the Advisor on Chronic Pain at the Department of Anesthesia, and as a vice-chair of the Chronic Pain Registry Committee at the Adult Chronic Pain Network Advisory for the Ministry of Health and Long-Term Care of Ontario. Dr. Gofeld devoted time and effort to developing the Neuromodulation Program at the St Michael’s Hospital and Chronic Pain education at the University of Toronto, where he was appointed as Associate Professor. He served as an Assessor for the College of Physicians and Surgeons of Ontario.
Jurgen Gotz
Jürgen Götz, PhD
Professor Jürgen Götz is Foundation Chair of Dementia Research and Director of the Clem Jones Centre for Ageing Dementia Research at the Queensland Brain Institute (University of Queensland, Australia). Prof. Götz is an internationally renowned expert in basic research on Alzheimer’s disease. He generated the first tau transgenic mouse model with an early AD phenotype. He provided evidence for the amyloid cascade hypothesis and identified a novel function of tau in mediating Aβ toxicity via Fyn. Recently, he used scanning ultrasound to clear Aβ and tau in Alzheimer's mice which was associated with improved memory functions.
Joo Ha Hwang
Joo Ha Hwang, MD, PhD
Dr. Joo Ha Hwang is a Professor of Medicine at Stanford University. He specializes in early detection of gastrointestinal malignancies including esophageal cancer, gastric (stomach) cancer, pancreatic cancer, bile duct cancer, and colon cancer. He has been performing research in the field of focused ultrasound since 2000, primarily investigating its potential to enhance drug delivery for the treatment of pancreatic cancer. He is also the principal investigator of a new Foundation-organized international registry for focused ultrasound treatment of pancreatic cancer.
Kullervo Hynynen
Kullervo Hynynen, PhD
Dr. Kullervo Hynynen is currently the Vice-President of Research and Innovation at the Sunnybrook Research Institute, a Professor in the Department of Medical Biophysics, and a Professor in the Institute of Biomaterials & Biomedical Engineering (IBBME) at the University of Toronto. He also holds the Temerty Chair in Focused Ultrasound Research at Sunnybrook Health Sciences Centre.
Young Sun Kim
Young-Sun Kim, MD
Dr. Young-sun Kim is a radiologist and works for the Uterine Fibroid Integrated Management Center at MINT Intervention Hospital in Seoul, Korea. He was previously an associate professor of department of Radiology of Samsung Medical Center, Sungkyunkwan University School of Medicine in Seoul, Korea. He currently performs clinical MR-guided high intensity focused ultrasound (MR-HIFU) ablation therapy for the treatment of uterine fibroids and preclinical translational research of HIFU for cancer treatment. He has published approximately 50 scientific papers as a primary author; Among them, about 40 papers were regarding image-guided tumor ablation such as radiofrequency ablation or HIFU.
Elisa Konofagou
Elisa E. Konofagou, PhD
Dr. Elisa Konofagou is the Robert and Margaret Hariri Professor of Biomedical Engineering and Professor of Radiology as well as Director of the Ultrasound and Elasticity Imaging Laboratory at Columbia University in New York City. Her main interests are in the development of novel elasticity imaging techniques and therapeutic ultrasound methods and, more notably, focused ultrasound in the brain for drug delivery and modulation, breast tumor ablation monitoring with harmonic motion imaging, myocardial elastography, electromechanical wave imaging, and pulse wave imaging with several clinical collaborations in the Columbia Presbyterian Medical Center and beyond.
Vibhor Krishna
Vibhor Krishna, MBBS
Dr. Vibhor Krishna is an Assistant Professor in the Department of Neurosurgery and Department of Neuroscience at The Ohio State University in Columbus, Ohio. He has expertise in deep brain stimulation, spinal cord stimulation, peripheral nerve stimulation, and focused ultrasound. As a surgeon-scientist, his research mission is to pursue cutting-edge translational research and leverage it to improve patient outcomes. His lab focuses on advancing personalized stereotactic targeting, standardizing neuromodulation treatments, and developing objective biomarkers for patient selection.
Cyril Lafon
Cyril Lafon, PhD
Dr. Cyril Lafon is a research director at INSERM and heads the LabTAU in Lyon, France. His early research included developing interstitial HIFU probes and ultrasound-induced hemostasis and the development of tissue mimicking phantoms for HIFU applications. His recent research interests focus on modeling ultrasound wave propagation and the development of ultrasonic therapeutic devices for thermal ablation or drug delivery.
Lipsman 140
Nir Lipsman, MD, PhD, FRCSC
Dr. Nir Lipsman is a neurosurgeon and scientist at Sunnybrook Research Institute and Sunnybrook Health Sciences Center, and an Assistant Professor in the Department of Surgery at the University of Toronto. He completed his medical degree at Queen’s University, and neurosurgical residency and PhD at the University of Toronto. He helped develop world's-first applications of focused ultrasound in tremor, Alzheimer’s Disease, ALS, and primary and secondary brain tumors. He is currently the Director of Sunnybrook’s Harquail Center for Neuromodulation and the Clinical Director of Sunnybrook’s Focused Ultrasound Centre of Excellence.
McDannold 140
Nathan McDannold, PhD
Dr. Nathan McDannold is a Research Associate at Brigham and Women’s Hospital and an Associate Professor of Radiology at Harvard Medical School. His research has focused on brain applications, drug delivery, and neurodegenerative diseases. A medical physicist, he has been a participant in the care of every focused ultrasound patient treated at BWH since 1996.
Emmanuel Messas
Emmanuel Messas, MD
Professor Emmanuel Messas is a Fellow of the European Society of Cardiology, as well as Head of Cardiovascular (CV) prevention and Vascular Medicine department and head of the CV ultrasound Echolab at Hopital Européen Georges Pompidou, Université of Paris and Inserm UMR 970, Paris, France. His main field of research is innovation in CV ultrasound imaging and therapy. For the past six years, his group funded a startup company, Cardiawave, which is headed and co-funded by Benjamin Bertrand. Bertrand developed a breakthrough disruptive technology on noninvasive ultrasound therapy, creating shockwaves on the aortic valve calcification in patients with severe symptomatic aortic valve stenosis. Pr. Messas is the principal investigator of the international first-in-men study on this application, and early promising results have been presented at multiple international cardiology meetings. Today, he continues this fruitful collaboration on innovation on ultrasound and cardiovascular disease.
Chrit Moonen
Chrit Moonen, PhD
Dr. Chrit Moonen is currently a professor at the Division of Imaging at the University Medical Center in Utrecht, the Netherlands. Previously, was the director of the laboratory “Molecular and Functional Imaging: from Physiology to Therapy” until 2011. He was chairman of the 2015 meeting of the International Society for Therapeutic Ultrasound (ISTU) and he received the organization's gold medal (Fry Award) in 2019. His recent work is mainly in MRI-guided focused ultrasound, image-guided drug delivery, and molecular and cellular imaging.
Jose Obeso
José A. Obeso, MD, PhD
Prof. José Obeso is director of the Neuroscience Center (CINAC) in Madrid, integrated into the HMPuerta del Sur General Hospital and Hospitales de Madrid healthcare network, Full Professor of Neurology in CEU-San Pablo University, and principal investigator in CIBERNED (Spanish Network for Neurodegeneration). In CINAC, Prof. Obeso heads a highly active team devoted to understanding and developing new treatments for Parkinson's disease and other movement disorders. More recently, his main interest has centered on the factors defining neuronal dopaminergic vulnerability and applying focused ultrasound to halt the progression of Parkinson´s disease.
Dennis Parker
Dennis L. Parker, PhD
Dr. Dennis Parker is a Professor of Radiology and Biomedical Informatics and past Director of the Utah Center for Advanced Imaging Research at the University of Utah. He is a medical physicist with over 40 years of experience in medical imaging research and image-guided therapies. Dr. Parker performed early experiments to test whether MRI could be used to measure temperature, and in the early 1980s, he published the first papers showing that MRI could be used to create images of temperature. More recently, he has developed some novel and highly efficient methods for monitoring temperature and measuring tissue elasticity in the fully insonified 3D volume for brain and breast applications.
Allison Payne
Allison H. Payne, PhD
Dr. Allison Payne is an Assistant Professor in the Department of Radiology and Imaging Sciences at the University of Utah and a member of the Focused Ultrasound Laboratory. She has led a team that has developed a breast magnetic resonance-guided focused ultrasound system that is currently in clinical trials. Her recent research investigates innovative and efficient imaging biomarkers for use in the monitoring and assessment of focused ultrasound therapies.
Lauren Powlovich
Lauren Powlovich, MD
Dr. Lauren Powlovich is Director of Special Projects at the Focused Ultrasound Foundation. Her role includes consulting on and participating in focused ultrasound-based research projects in collaboration with University of Virginia as well as creating and maintaining the Foundation's informational documents. Lauren previously worked at the University of Virginia as a resident Anesthesiologist. She graduated from the University of Vermont with a BA in Biology and later received her MD from the Larner College of Medicine at The University of Vermont.
Richard Price
Richard J. Price, PhD
Dr. Richard Price is a Professor of Biomedical Engineering and Radiology & Medical Imaging at the University of Virginia. He is also Research Director of the UVa Focused Ultrasound Center and Director of the UVa Beckman Scholar Program. He has been studying ultrasound-targeted drug and gene delivery for approximately 20 years. He was amongst the first investigators to observe that interactions between contrast agent microbubbles and ultrasound can be used to open endothelial barriers for targeted nanoparticle delivery. Using these results as a platform, he determined how ultrasound parameters may be adjusted to optimize nanoparticle delivery, developed the approach as a means for stimulating collateral blood vessel growth in skeletal muscle, and demonstrated its utility as a means for achieving targeted skeletal muscle transfection.
Viola Rieke
Viola Rieke, PhD
Dr. Viola Rieke is a Research Associate Professor in the Department of Radiology and Imaging Sciences at the University of Utah School of Medicine. Her research focuses on developing MR pulse sequences and reconstruction algorithms to guide and monitor ultrasound thermal therapy, particularly focused ultrasound. Her current clinical and preclinical research includes transcranial focused ultrasound, developing new methods for ablation and neuromodulation in the spine, and real-time temperature monitoring in moving organs during focused ultrasound ablation and hyperthermia. Dr. Reike's long-term career goal is to continually contribute to the field of MR-guided ultrasound therapy and interventional MRI and to make a fundamental impact on patient care by exploring new, less-invasive treatment options.
Naren Sanghvi
Narendra Sanghvi, PhD
Dr. Naren Sanghvi is Chief Scientific Officer of SonaCare Medical, LLC, co-founder of Focus Surgery Inc. (a subsidiary of SonaCare Medical), and a pioneer in the field of high intensity focused ultrasound (HIFU). He is the inventor and developer of the Sonablate® HIFU device for the treatment of prostate disease. He served at the Indiana University School of Medicine as an associate professor and senior research scientist in the Department of Physiology and Biophysics. Dr. Sanghvi worked with Prof. F. J. Fry and developed the first clinical ultrasound image guided HIFU device for the treatment of brain cancer in 1972.
Karun V. Sharma
Karun V. Sharma, MD, PhD
Dr. Karun Sharma is the Director of Interventional Radiology at Children's National Health System, and an Associate Professor of Radiology and Pediatrics at the George Washington University School of Medicine and Health Sciences. Dr. Sharma’s specialties are diagnostic radiology and interventional radiology, with a keen interest in minimally invasive and noninvasive treatment techniques. He leads the Image-Guided Non-Invasive Therapeutic Energy (IGNITE) program, a collaboration of the Sheikh Zayed Institute and the departments of Radiology, Oncology, Surgery, and Anesthesiology at Children’s National.
Howard Soule
Howard R. Soule, PhD
Dr. Howard Soule is Chief Science Officer at the Prostate Cancer Foundation (PCF), where he coordinates global academic, government, and biopharmaceutical sector research activity and is responsible for the implementation of the PCF's global research strategies. He is also a member of the Department of Defense Prostate Cancer Research Program Integration Panel. Dr. Soule has been with the PCF for over 20 years.  He received a PhD from Baylor College of Medicine in Virology and Epidemiology and was a Post-Doctoral Fellow in Immunology and Vascular Biology at the Scripps Research Institute.
Joan Vidal Jové
Joan Vidal-Jové, MD, PhD
Dr. Joan Vidal-Jové leads the first Oncological FUS-HIFU Unit in Spain at the Hospital University Mutua Terrassa. He is also Director of Interventional Oncology at the Institute Khuab in Barcelona. He has developed his career in various institutions in the U.S. and Europe, both in the healthcare field, research in the pharmaceutical industry and public administration. He has performed more than 200 oncological cases with focused ultrasound, including pancreatic and liver tumors. Dr. Vidal-Jové will also serve as the honorary president of the 7th International Symposium on Focused Ultrasound. 
Emily White
Emily J. White, MD
Dr. Emily White is Director of Operations at the Focused Ultrasound Foundation. She has been a private consultant working in operations and business development support in the healthcare and medical start-up space. Her clients have included everything from a 4,000+ employee, publicly traded, health care company to a brand new start-up with two employees. In 2018, Dr. White expanded her role to include Managing Director of FUS Partners, the Foundation’s efforts to help the focused ultrasound industry’s commercialization efforts and expand their access to the MedTech capital markets. 
Frank Wolfram
Frank Wolfram, PhD
Professor Frank Wolfram studied Medical Physics at the Technical University Ilmenau in Germany and University Hospital Linköping in Sweden, where he studied Ultrasound Inhalation Therapy. He continued working with lung-related projects in medical ultrasound industry and at the Univ. Hospital Aachen in Germany. In 2011, Prof. Wolfram initiated a lung project using focused ultrasound at the SRH Wald-Klinikum Gera in Germany and graduated as PhD in 2015 from the medical faculty of the Friedrich Schiller University Jena, Germany, specializing in noninvasive lung cancer ablation using therapeutic ultrasound.
Graeme Woodworth
Graeme F. Woodworth, MD
Dr. Graeme Woodworth is a neurosurgeon-scientist and director of the Brain Tumor Treatment and Research Center at the University of Maryland School of Medicine. In the laboratory, his team is developing new therapeutic strategies to improve the treatments and outcomes for patients with malignant brain tumors. Recent work has focused on optimizing reproducible and safe focused ultrasound  treatments in small animals, including treating areas within the non-enhancing regions of genetically engineered rat gliomas. His clinical research team is leading the first-in-human clinical trials of MRI-guided focused ultrasound-mediated blood brain barrier disruption (MRgFUS-BBBD) in the United States. These studies are designed to evaluate the safety and feasibility of MRgFUS BBBD, with the eventual goal of using this technology to improve therapeutic delivery to and effects against intrinsic brain tumors.
Zhen Xu
Zhen Xu, PhD
Dr. Zhen Xu is a tenured Associate Professor in the Department of Biomedical Engineering at the University of Michigan. She received a BSE degree in biomedical engineering from Southeast University in Nanjing, China, in 2001, and her MS and PhD degrees - both in biomedical engineering - from the University of Michigan in 2003 and 2005, respectively. She is a pioneer in developing histotripsy, and her research focuses on ultrasound therapy, particularly the applications of histotripsy for noninvasive surgeries. 
Seung Schik Yoo
Seung-Schik Yoo, PhD, MBA
Dr. Seung-Schik Yoo is an Associate Professor of Radiology at Harvard Medical School and a Director of Neuromodulation and Tissue Engineering Laboratory (NTEL), Brigham and Women's Hospital. He also serves as a faculty member of Mind Brain Behavior at Harvard University. He has done early pioneering works in developing real-time functional MR-imaging to interpret the human mind and applied the technology to interface the brain function with machines and computers. He has also developed a mode of noninvasive brain stimulation modality which utilizes focused ultrasound waves to control regional neural functions, including the activity of the brain. He is primarily interested in advancing the technique for various neurotherapeutics, but also likes to seek out new ways to link thoughts/brain processes between individuals.